NFKB1 and neoplasm: Thus, XIAP and survivin, which are members of the family of apoptosis inhibitory proteins that are regulated by NF-κB, are regarded as therapeutic targets because of their involvement in tumor cells, especially in chemotherapeutic resistance, cell proliferation, and angiogenesis.